Highlights
- Vitalant received a $46,421,050 contract from the CDC to study SARS-CoV-2 antibody prevalence nationwide.
- The award, identified as contract 75D30120C08170, lists Arizona as the place of performance.
- Vitalant, headquartered at 6210 E. Oak Street, traces its origins to 1943, according to a Dun & Bradstreet profile.
- No action date is listed in the USAspending record; the contract detail page is publicly accessible.
Vitalant, the blood services organization with operations in Arizona, landed a $46,421,050 federal contract from the Department of Health and Human Services' Centers for Disease Control and Prevention to characterize SARS-CoV-2 antibody levels in the U.S. population, according to USAspending.gov records.
The contract, identified as award 75D30120C08170, lists Arizona as the place of performance. The scope of work, as described in the federal procurement record, is to "characterize seroprevalence of SARS CoV-2 antibodies in the US population."
A Dun & Bradstreet company profile lists Vitalant's address as 6210 E. Oak Street and notes the organization was founded in 1943. A rate agreement document from Vitalant's research office identifies the organization as formerly operating under the name Blood Systems, Inc.
What is Vitalant's role in this contract?
The federal procurement record designates Vitalant as the sole recipient of award 75D30120C08170, with the CDC as the awarding component within HHS. The contract description focuses on seroprevalence characterization, a method of measuring how widely antibodies have spread through a population by testing blood samples, which aligns with Vitalant's blood-collection operations.
The USAspending.gov detail page for the award does not list a specific action date. The full contract record is publicly available at the USAspending award page.
Sources
Every factual claim in this article traces to one of the sources below. See how we work for the editorial process.
- USAspending.gov retrieved 19/05/2026 08:22
- dnb.com retrieved 19/05/2026 08:22
- research.vitalant.org retrieved 19/05/2026 08:22
Authored by The Scottsdale Signal. Drafted by AI from primary-source material under our beat-specific editorial guides; reviewed by humans before publish under our five-gate process. Sources retrieved at 19/05/2026 08:22. Every claim traces to a source.
